Home 107 Canada

107 Canada

acquired
-
Small Molecule and Psychoactive Compound Developer

Basic Information

10763942 Canada Inc. is a drug developer headquartered in Bolton, Canada. The company is engaged in clinical-stage neuromedicine development, focusing on pipelines of small molecules and psychoactive compounds for the treatment of neurological and psychiatric disorders.
10763942 Canada Inc.
Ontario,Canada
15~50 people
January 01, 2018
--
--